Replies to post #67141 on CV Sciences Inc (CVSI)

[ap17]

CW is way overpriced, and with RED INK prospects to 2023, it's going to have lots of downward pressure on the SP.

[JDunbar]

Legend, stock price is not market caps and revenues only. People are paying more for this stock because it has solid potential. Not "future patent" potential, or "maybe we'll get a buyout" potential. CW's losses are from investing in vertically-integrated infrastructure - who do you think is more prepared to meet scaled-up demand if/when the FDA regs come through? You are already six months behind in providing pet products (IF they put out product at their proposed date) - what will it be like with dietary supplements, a much broader field of product? You think CWEB has made a mistake, sitting on a supply of patented, domestic hemp of unprecedented quality because current prices are down? What happens if the price of Euro-imported hemp goes up? Or bottlenecks happen from crop failures, tariffs, or the logistics of suddenly wanting 3 million, instead of one million barrels? Tomorrow, CWEB are almost doubling their outreach and product seamlessly … will CVSI find things that easy? EDIT: Thank you Ap17, for making me smile ha ha